Cyclin E-CDK2 regulates cancer cell transcriptional program and response to immunotherapy through BRD4
Chen Chu, Shanshan Zheng, Ning Mitchell, Zheqi Li et autres
0 citationsMolecular Cell
Anne Fassl
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
103Publications signalées
2667Citations signalées
6Affiliations récentes
Institutions déclarées
Domaines associés
Cytokine Signaling Pathways and InteractionsCancer-related Molecular PathwaysMicroRNA in disease regulationAdvanced Glycation End Products researchinterferon and immune responses
Publications récentes
Supplementary Table S2 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
Supplementary Table S1 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
Supplementary Table S7 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
Supplementary Table S8 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
Supplementary Figures S1-S9 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
Supplementary Table S3 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
Supplementary Data S3 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
Supplementary Table S6 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
Supplementary Table S4 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
Supplementary Table S5 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
Data from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Franziska Michor, Marco Seehawer, Andriana Patmanidis et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.